Search results for "Allergy"

showing 10 items of 3181 documents

Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.

2014

Abstract Late-onset myasthenia gravis (LOMG) has become the largest MG subgroup, but the underlying pathogenetic mechanisms remain mysterious. Among the few etiological clues are the almost unique serologic parallels between LOMG and thymoma-associated MG (TAMG), notably autoantibodies against acetylcholine receptors, titin, ryanodine receptor, type I interferons or IL-12. This is why we checked LOMG patients for two further peculiar features of TAMG – its associations with the CTLA4 high/gain-of-function  +49A/A genotype and with increased thymic export of naive T cells into the blood, possibly after defective negative selection in AIRE-deficient thymomas. We analyzed genomic DNA from 116 …

Malemedicine.medical_specialtyGenotypeThymomaT-LymphocytesImmunologyDNA Mutational AnalysisRecent Thymic EmigrantLate onsetCell CountThymus GlandBiologyPeripheral blood mononuclear cellWhite PeopleGene FrequencyInternal medicineGenotypeMyasthenia GravismedicineImmune ToleranceImmunology and AllergyHumansCTLA-4 AntigenGenetic Predisposition to DiseaseGenetic Association StudiesAgedPeripheral tolerance inductionAged 80 and overPolymorphism GeneticThymocytesT-cell receptor excision circlesAutoantibodyCell DifferentiationThymus NeoplasmsMiddle Agedmedicine.diseaseMyasthenia gravisEndocrinologyImmunologyFemaleJournal of autoimmunity
researchProduct

Leucocyte Interferon-alpha for Patients with Chronic Hepatitis C Intolerant to Other alpha-Interferons

2003

Background: Alpha-interferon (α-IFN) is the treatment of choice for chronic hepatitis C but most patients experience adverse effects which sometimes lead to the suspension of therapy. Recently, higher doses of α-IFN or prolonged therapy have increased the number of cases of intolerance. Study Design: In this open study we evaluated the efficacy and safety of leucocyte interferon-alpha (IFNα) [6MU three times a week] in 43 patients with chronic hepatitis C who had been intolerant to previous treatment courses with recombinant or lymphoblastoid IFNα. All patients were treated for 6 months and followed-up for an additional 6 months. End of treatment responders were patients in whom hepatitis C…

Malemedicine.medical_specialtyHepatitis C virusAlpha interferonmedicine.disease_causeAntiviral AgentsInjections IntramuscularGastroenterologyPharmacotherapyInternal medicineLeukocytesHumansImmunology and AllergyMedicinePharmacology (medical)Adverse effectPharmacologybiologybusiness.industryInterferon-alphaGeneral MedicineHepatitis C ChronicMiddle AgedMolecular medicineAnti-thyroid autoantibodiesDiscontinuationPharmacology Toxicology and Pharmaceutics (all)Immunologybiology.proteinFemaleAntibodybusinessBiotechnologyBioDrugs
researchProduct

Hereditary Angioedema with Normal C1 Inhibitor

2013

Until recently it was assumed that hereditary angioedema was a disease that results exclusively from a genetic deficiency of the C1 inhibitor. In 2000, families with hereditary angioedema, normal C1 inhibitor activity, and protein in plasma were described. Since then, numerous patients and families with that condition have been reported. Most of the patients were women. In many of the affected women, oral contraceptives, hormone replacement therapy containing estrogens, and pregnancies triggered the clinical symptoms. In some families mutations in the coagulation factor XII (Hageman factor) gene were detected.

Malemedicine.medical_specialtyImmunologyCoagulation Factor XIIC1-inhibitorDiagnosis DifferentialPregnancyRisk FactorsInternal medicinemedicineHumansImmunology and AllergyHereditary Angioedema Type IIIAngioedemaFactor XIIbiologyAngioedemabusiness.industryAngioedemas Hereditarymedicine.diseaseEndocrinologyTransgender hormone therapyFactor XIIMutationHereditary angioedemabiology.proteinFemaleDifferential diagnosismedicine.symptombusinessComplement C1 Inhibitor ProteinImmunology and Allergy Clinics of North America
researchProduct

Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis.

2004

Clinical and experimental studies have shown increased concentrations of TNF-α and its soluble receptors in serum of patients with acute pancreatitis. In this work, we have investigated the time-course of TNF-α and its soluble receptors during taurocholate-induced acute pancreatitis. In addition, since TNF-α itself could mediate the shedding of its receptors, we have assessed the effect of inhibiting TNF-α production on the release of soluble TNF-α receptors in experimental acute pancreatitis. Our results indicate that soluble receptors are released in the early stages of the disease and this increase is concomitant with the release of TNF-α, which is mainly bound to specific proteins. The …

Malemedicine.medical_specialtyImmunologyInflammationBiochemistryDNA-binding proteinReceptors Tumor Necrosis FactorPentoxifyllineInternal medicinemedicineSIRSImmunology and AllergyAnimalsPentoxifyllineRats WistarReceptorMolecular BiologyInflammationbusiness.industryTumor Necrosis Factor-alphaHematologymedicine.diseasesTNF-αRRatsDisease Models AnimalEndocrinologyPancreatitisSolubilityTNF-αAcute DiseasePancreatitisAcute pancreatitisTumor necrosis factor alphamedicine.symptombusinessmedicine.drugCytokine
researchProduct

Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and imm…

2015

Objective: The aim of this study was to investigate the relationship between immunoinflammatory markers and indexes of arterial stiffness in patients with seronegative spondyloarthritis (SpA).Method: We enrolled consecutive patients with inflammatory seronegative SpA referred to a rheumatology outpatient clinic. Control subjects were patients admitted in the same period for any cause other than chronic inflammatory disease or acute cardiovascular and cerebrovascular events. Carotid-femoral pulse wave velocity (PWV) was measured and the aortic pressure waveform was used to calculate the augmentation index (Aix). We also evaluated plasma levels of C-reactive protein (CRP), interleukin (IL)-1β…

Malemedicine.medical_specialtyImmunologyInterleukin-1betaPulse Wave AnalysiGastroenterologySeverity of Illness IndexRheumatologyInternal medicinemedicineImmunology and AllergyOutpatient clinicInterleukin 6Pulse wave velocityCytokineMultivariate Analysibiologybusiness.industryInterleukin-6Tumor Necrosis Factor-alphaBiomarkers; C-Reactive Protein; Case-Control Studies; Cytokines; Female; Humans; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Pulse Wave Analysis; Spondylarthritis; Tumor Necrosis Factor-alpha; Vascular Stiffness; Severity of Illness IndexC-reactive proteinSpondylarthritiInterleukinGeneral MedicineBiomarkerMiddle Agedmedicine.diseaseRheumatologyBlood pressureC-Reactive ProteinImmunologybiology.proteinArterial stiffnessFemalebusinessCase-Control StudieHumanVascular Stiffne
researchProduct

Typical Kawasaki disease with atypical pneumonia: a paediatric case report.

2020

Patients with complete Kawasaki disease (KD), in approximately 10–20% of cases, fail to defervesce with intravenous immunoglobulin (IVIG) infusion and acetylsalicylic acid (ASA) (1–5). Failure is u...

Malemedicine.medical_specialtyImmunologyMEDLINEMucocutaneous Lymph Node SyndromeMethylprednisolone03 medical and health sciences0302 clinical medicineRheumatologyhemic and lymphatic diseasesImmunology and AllergyMedicineHumans030212 general & internal medicineGlucocorticoids030203 arthritis & rheumatologybiologybusiness.industryImmunoglobulins IntravenousGeneral MedicinePneumoniamedicine.diseaseDermatologyKawasaki diseaseatypical pneumoniaIVIG treatmentpaediatric caseTreatment OutcomeAtypical pneumoniaChild Preschoolbiology.proteinKawasaki diseaseAntibodybusinessTomography X-Ray ComputedScandinavian journal of rheumatology
researchProduct

Kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass

2018

Abstract Background Endocan plays an important role in the processes of inflammation and infection. The use of cardiopulmonary bypass (CPB) during cardiac surgery can induce an inflammatory response. We aimed to describe the kinetics of endocan in patients undergoing cardiac surgery with and without the use of CPB. Methods Single-centre, observational study with retrospective analysis of prospectively collected data, to compare the kinetics of endocan in patients undergoing isolated coronary artery bypass graft (CABG) surgery. Endocan was measured at induction of general anesthesia (baseline), and at 6, 24, 48 and 72 h after the end of surgery. Patients were classified into two groups, name…

Malemedicine.medical_specialtyInflammatory responseImmunology030204 cardiovascular system & hematologyBiochemistrylaw.invention03 medical and health sciences0302 clinical medicinelawCardiopulmonary bypassRetrospective analysisHumansImmunology and AllergyMedicineIn patientProspective StudiesCoronary Artery BypassMolecular BiologyAgedRetrospective StudiesCardiopulmonary BypassLungbusiness.industry030208 emergency & critical care medicineHematologyCabg surgeryCoronary VesselsNeoplasm ProteinsCardiac surgeryKineticssurgical procedures operativemedicine.anatomical_structureAnesthesiaFemaleProteoglycansbusinesscirculatory and respiratory physiologyArteryCytokine
researchProduct

Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients.

2005

Background:  Acetylcholine (ACh) plays an important role in smooth muscle contraction and in the development of airway narrowing; preliminary evidences led us to hypothesize that ACh might also play a role in the development of airways inflammation in chronic obstructive pulmonary disease (COPD). Methods:  We evaluated the concentrations of leukotriene B4 (LTB4) in induced sputum, and the expression of Ach M1, M2, and M3 receptors in sputum cells (SC) obtained from 16 patients with COPD, 11 smokers, and 14 control subjects. The SC were also treated with ACh and the production of LTB4 assessed in the presence or absence of a muscarinic antagonist (oxitropium). In blood monocytes, we evaluate…

Malemedicine.medical_specialtyLeukotriene B4NeutrophilsImmunologyProtozoan ProteinsLeukotriene B4chemistry.chemical_compoundPulmonary Disease Chronic ObstructiveInternal medicineMuscarinic acetylcholine receptorImmunology and AllergyMedicineHumansReceptorCells CulturedAgedFlavonoidsCOPDMitogen-Activated Protein Kinase 3business.industryCalcium-Binding ProteinsSputumMuscarinic acetylcholine receptor M3Muscarinic antagonistSmooth muscle contractionMiddle Agedmedicine.diseaseImmunohistochemistryReceptors MuscarinicAcetylcholinerespiratory tract diseasesChemotaxis LeukocyteEndocrinologychemistryLeukocytes MononuclearFemalebusinessAcetylcholinemedicine.drugAllergy
researchProduct

Helicobacter pylori and some aspects of gut microbiota in children

2018

Helicobacter pylori infection in children differs from infection in adults in many aspects. The rate of infection, epidemiology, clinical presentations and complications, the applicability of diagnostic tests, antibiotic resistance, treatment options, and success rates differ significantly. Due to all these differences, management guidelines for children and adults differ also substantially. In 2017, the Updated ESPGHAN and NASPGHAN Guidelines on the management of H. pylori infection in children were published, emphasizing the differences in clinical presentation and indications for treatment, stating that the primary goal of clinical investigation in children is to identify the cause of up…

Malemedicine.medical_specialtyLongitudinal studyAllergyGut floraHelicobacter InfectionsAtopy03 medical and health sciences0302 clinical medicineAntibiotic resistanceInternal medicineEpidemiologymedicineHumans030212 general & internal medicineHelicobacter pyloribiologybusiness.industryIncidence (epidemiology)GastroenterologyGeneral MedicineHelicobacter pyloribiology.organism_classificationmedicine.diseaseAnti-Bacterial AgentsGastrointestinal MicrobiomeTreatment OutcomeInfectious DiseasesFemale030211 gastroenterology & hepatologybusinessHelicobacter
researchProduct

N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia.

2006

We assessed the implication of Th (helper)-cells and the modulation of the Th1/Th2 dichotomy by n-3 polyunsaturated fatty acids (PUFA) in type I diabetic pregnancy (DP) and macrosomia. Female gestant rats fed a standard diet or n-3 PUFA regimen were rendered diabetic by administration of five low doses of streptozotocin. The macrosomic (MAC) offspring were sacrificed at the age of 90 days. The mRNAs of IL-2 and IFN-gamma (Th1 cytokines) and IL-4 (Th2 cytokine) were downregulated in the pancreas and spleen of diabetic pregnant rats. The levels of IL-10 mRNA, another Th2 cytokine, were unchanged in the spleen or upregulated in the pancreas of these animals. Feeding an n-3 PUFA diet to rats wi…

Malemedicine.medical_specialtyOffspringImmunologyPregnancy in DiabeticsSpleenBiologyFetal MacrosomiaTh2 CellsDownregulation and upregulationPregnancyInternal medicineDiabetes mellitusFatty Acids Omega-3medicineImmunology and AllergyAnimalsRNA MessengerRats Wistarchemistry.chemical_classificationPregnancyFatty AcidsTh1 CellsStreptozotocinmedicine.diseaseDietRatsmedicine.anatomical_structureEndocrinologyCholesterolDiabetes Mellitus Type 1chemistryCytokinesFemalePancreasSpleenmedicine.drugPolyunsaturated fatty acidJournal of autoimmunity
researchProduct